Market Overview

UPDATE: J.P. Morgan Raising Price Target on Mako Surgical


J.P. Morgan Chase & Co. is out with a research report on Mako Surgical (NASDAQ: MAKO) and it is raising its price target to $37 from $28, but is keeping its Neutral rating after it reported earnings.

In a note to clients, J.P. Morgan Chase & Co. writes, "Mako reported 3Q results Wednesday night, with sales of $20.0M topping Street consensus by $600k. Mako sold a total of 11 systems in the quarter, which was one system light of both our estimate and Street consensus. The company reported a net loss of $0.24/share, which was $0.02 below the Street as well as our forecast. Despite underwhelming 3Q results, key updates including: (1) two systems placed at HSS; and (2) a faster trajectory of hip upgrades should give investors increased confidence around Mako's 2012 outlook heading into year-end."

Shares of MAKO lost $2.51 yesterday to close at $33.34, a loss of 7%.

Posted-In: J.P. Morgan Chase & Co.Analyst Color Price Target Analyst Ratings


Related Articles (MAKO)

View Comments and Join the Discussion!

Latest Ratings

PLCEB. Riley FBRDowngrades59.0
ASPUCanaccord GenuityMaintains11.0
AAPLEvercore ISI GroupMaintains305.0
THTXMackie ResearchUpgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Legg Mason Reports Assets Under Management for October of $629B

Wedbush Raises EPS Estimates on Cisco Systems